Shanton Pharma
Organisation
Trials
Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.
Phase 2, Active, not recruiting, 87 people, 19 Jan 2023
Sources: clinicaltrials.gov
Organisation
Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.
Phase 2, Active, not recruiting, 87 people, 19 Jan 2023
Sources: clinicaltrials.gov